Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Collet

Showing results (251-260 of 408) with videos related to

Pageof 41
Sort By:
Lancet (London, England)|December 26, 2008
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort studyJean-Philippe Collet, Jean-Sébastien Hulot, Anna Pena, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 14, 2017
2017 EACTS Guidelines on perioperative medication in adult cardiac surgeryMiguel Sousa-Uva, Stuart J Head, Milan Milojevic, et al.
Archives of Cardiovascular Diseases|December 22, 2022
Beta-blocker prescription and outcomes in uncomplicated acute myocardial infarction: Insight from the ePARIS registryGaspard Suc, Michel Zeitouni, Niki Procopi, et al.
Journal of the American College of Cardiology|December 22, 2018
Association of Serum Cholesterol Efflux Capacity With Mortality in Patients With ST-Segment Elevation Myocardial InfarctionMaryse Guerin, Johanne Silvain, Julie Gall, et al.
Archives of Cardiovascular Diseases|August 12, 2009
Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trialJean-Philippe Collet, Gilles Montalescot, Philippe Gabriel Steg, et al.
The Canadian Journal of Cardiology|April 3, 2022
Outcomes Following Patent Foramen Ovale Percutaneous Closure According to the Delay From Last Ischemic EventPaul Guedeney, Jules Mesnier, Michel Zeitouni, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 5, 2022
ESC/EAS guidelines for the detection, prevention, and treatment of individuals at risk of a first myocardial infarction: effect of 5 years of updates and the new SCORE2David Sulman, Michel Zeitouni, Johanne Silvain, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 26, 2018
Biomarkers of Thrombosis in ST-Segment Elevation Myocardial Infarction: A Substudy of the ATOLL Trial Comparing Enoxaparin Versus Unfractionated HeparinJohanne Silvain, Stephen A O'Connor, Yan Yan, et al.
International Journal of Cardiology|July 2, 2011
Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factorsOlivier Barthélémy, Tobias Limbourg, Jean Philippe Collet, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 4, 2018
Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysisJean-Philippe Collet, Mathieu Kerneis, Benoit Lattuca, et al.
Pageof 41

Showing results (251-260 of 408) with videos related to

Sort By:
Pageof 41
Lancet (London, England)|December 26, 2008
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort studyJean-Philippe Collet, Jean-Sébastien Hulot, Anna Pena, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 14, 2017
2017 EACTS Guidelines on perioperative medication in adult cardiac surgeryMiguel Sousa-Uva, Stuart J Head, Milan Milojevic, et al.
Archives of Cardiovascular Diseases|December 22, 2022
Beta-blocker prescription and outcomes in uncomplicated acute myocardial infarction: Insight from the ePARIS registryGaspard Suc, Michel Zeitouni, Niki Procopi, et al.
Journal of the American College of Cardiology|December 22, 2018
Association of Serum Cholesterol Efflux Capacity With Mortality in Patients With ST-Segment Elevation Myocardial InfarctionMaryse Guerin, Johanne Silvain, Julie Gall, et al.
Archives of Cardiovascular Diseases|August 12, 2009
Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trialJean-Philippe Collet, Gilles Montalescot, Philippe Gabriel Steg, et al.
The Canadian Journal of Cardiology|April 3, 2022
Outcomes Following Patent Foramen Ovale Percutaneous Closure According to the Delay From Last Ischemic EventPaul Guedeney, Jules Mesnier, Michel Zeitouni, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 5, 2022
ESC/EAS guidelines for the detection, prevention, and treatment of individuals at risk of a first myocardial infarction: effect of 5 years of updates and the new SCORE2David Sulman, Michel Zeitouni, Johanne Silvain, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 26, 2018
Biomarkers of Thrombosis in ST-Segment Elevation Myocardial Infarction: A Substudy of the ATOLL Trial Comparing Enoxaparin Versus Unfractionated HeparinJohanne Silvain, Stephen A O'Connor, Yan Yan, et al.
International Journal of Cardiology|July 2, 2011
Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factorsOlivier Barthélémy, Tobias Limbourg, Jean Philippe Collet, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 4, 2018
Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysisJean-Philippe Collet, Mathieu Kerneis, Benoit Lattuca, et al.
Pageof 41